跳至主要内容
临床试验/JPRN-UMIN000001436
JPRN-UMIN000001436已完成未知

Randomized controlled trail on efficacy and safety of Losartan 50 mg/HCTZ 12.5 mg and Titrated Angiotensin Receptor Blockers (ARBs) in Patients who have Hypertension with Diabetes mellitus - SIMPL II

SIMPL OSAKA INVESYGATORS (Masatsugu Hori)0 个研究点目标入组 300 人开始时间: 2008年10月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
30years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • - Patients with IDDM - Patients with nephropathy(UACR>300mg/dL). - Patients with HbA1c>10%. - Patients with insulin treatment. - Patients with poor controlled hypertension (SBP>180mmHg and DBP>110mmHg) - Patients with a critical liver disease (ALT or AST is over 3 times of normal values). - Patients with gout. - Patients with any severe cardiovascular events with hospitalization within the 6 months proior to informed concent. - Patients is pregnant or brest feeding or is a femele expecting conceive within the projected duration of the study. - Patients with secondary hypertension. - Patients with non-diabetic renaldisaeses such as glomerulonaphritis or polycystic kidney eta. - Patients with heart failure (above NYHA III) - Patients with poor controlled arythmia. - Patients treated with diuretics. - Patients has allagy against therapy drugs. - Patients who are considered to be not eligible to thye study by the investigator due to medical reason.

研究者

发起方
SIMPL OSAKA INVESYGATORS (Masatsugu Hori)

相似试验